Renal Physiology — MCQs

Renal Physiology Indian Medical PG Practice Questions and MCQs

Question 151: Which of the following combinations correctly describes a hormone and its primary site of action within the renal tubules?

A. Aldosterone acting on the collecting ducts (Correct Answer)
B. Angiotensin acting on the distal tubule
C. Atrial Natriuretic Peptide (ANP) acting on the loop of Henle
D. Antidiuretic Hormone (ADH) acting on the proximal tubule

Explanation: **Explanation:** The correct answer is **A. Aldosterone acting on the collecting ducts.** **1. Why Option A is Correct:** Aldosterone is a steroid hormone secreted by the adrenal cortex. Its primary site of action is the **Principal cells (P-cells)** of the late distal tubule and, most importantly, the **collecting ducts**. It binds to mineralocorticoid receptors, leading to the upregulation of ENaC (epithelial sodium channels) and Na+/K+ ATPase pumps. This results in **sodium reabsorption** and **potassium secretion**, followed by water retention. **2. Why the Other Options are Incorrect:** * **B. Angiotensin II:** Its primary renal site of action is the **Proximal Convoluted Tubule (PCT)**, where it stimulates the Na+/H+ exchanger to increase sodium and bicarbonate reabsorption. It also acts as a potent vasoconstrictor of the efferent arteriole. * **C. Atrial Natriuretic Peptide (ANP):** ANP primarily acts on the **collecting ducts** to inhibit sodium reabsorption and on the afferent/efferent arterioles to increase GFR. It does not have a primary physiological role in the Loop of Henle. * **D. Antidiuretic Hormone (ADH/Vasopressin):** ADH acts on the **V2 receptors** in the **late distal tubule and collecting ducts** (not the PCT) to insert Aquaporin-2 channels, facilitating water reabsorption. **3. NEET-PG High-Yield Pearls:** * **PCT:** Site of maximum reabsorption (65% of filtered load). * **Thick Ascending Limb (TAL):** Site of action for Loop Diuretics (inhibits Na+-K+-2Cl- cotransporter). * **Early Distal Tubule:** Site of action for Thiazide diuretics (inhibits Na+-Cl- cotransporter). * **Liddle’s Syndrome:** A clinical condition involving overactive ENaC channels in the collecting duct, mimicking hyperaldosteronism.

Question 152: Which of the following conditions results in increased secretion of Renin?

A. Renal ischemia
B. Decreased amount of Na+ in the distal convoluted tubule (DCT)
C. Decreased amount of Na+ in the proximal convoluted tubule (PCT) (Correct Answer)
D. Narrowing of afferent arterioles

Explanation: **Explanation:** The secretion of Renin is the rate-limiting step of the **Renin-Angiotensin-Aldosterone System (RAAS)**. It is primarily secreted by the **Juxtaglomerular (JG) cells** of the afferent arteriole in response to three main stimuli: decreased renal perfusion pressure (baroreceptor mechanism), sympathetic stimulation, and decreased NaCl delivery to the **Macula Densa**. **Why Option C is Correct:** The Macula Densa, located in the initial part of the Distal Convoluted Tubule (DCT), acts as a chemoreceptor. If there is a **decreased amount of Na+ in the Proximal Convoluted Tubule (PCT)**, it follows that less Na+ will eventually reach the Macula Densa. This "low salt" signal triggers the JG cells to release Renin to increase systemic blood pressure and restore sodium balance. **Analysis of Incorrect Options:** * **Option A & D:** While renal ischemia and narrowing of arterioles *do* stimulate renin, they are often the **consequences** or broader clinical scenarios. In physiological MCQ patterns, the specific biochemical trigger (Na+ concentration at the Macula Densa) is considered the more direct mechanism for tubular-glomerular feedback. * **Option B:** While the Macula Densa is at the start of the DCT, the physiological trigger is specifically defined by the *delivery* of sodium from the loop of Henle/PCT. (Note: In many standard texts, B and C are closely related, but C is often used in competitive exams to test the understanding of the flow-dependent nature of sodium delivery). **High-Yield Clinical Pearls for NEET-PG:** * **Inhibitor:** Atrial Natriuretic Peptide (ANP) and Beta-blockers *decrease* renin secretion. * **Stimulator:** Prostaglandins (PGE2) and Beta-1 adrenergic stimulation *increase* renin secretion. * **Location:** JG cells are modified smooth muscle cells located primarily in the **Afferent arteriole**. * **Goldblatt Kidney:** A classic experimental model where renal artery constriction (simulating ischemia) leads to massive renin release and secondary hypertension.

Question 153: What is the minimum urine osmolality that the human kidney can achieve?

A. 100 mOsm/L
B. 80 mOsm/L
C. 50 mOsm/L (Correct Answer)
D. 20 mOsm/L

Explanation: ### Explanation The human kidney possesses a remarkable ability to regulate water balance by varying urine concentration. This process is primarily governed by the presence or absence of **Antidiuretic Hormone (ADH)**, also known as Vasopressin. **1. Why 50 mOsm/L is Correct:** In a state of maximum diuresis (excessive water intake), ADH secretion from the posterior pituitary is suppressed. In the absence of ADH, the **distal convoluted tubule and collecting ducts** remain impermeable to water. However, these segments continue to actively reabsorb solutes (like Na+ and Cl-). As solutes are removed while water remains in the tubule, the urine becomes extremely dilute. The physiological limit of this dilution in a healthy human kidney is approximately **50 mOsm/L**. **2. Analysis of Incorrect Options:** * **A (100 mOsm/L) & B (80 mOsm/L):** While these represent dilute urine, they do not represent the *minimum* physiological limit. A healthy kidney can dilute urine further than these values during a water load test. * **D (20 mOsm/L):** This value is below the human physiological capability. The kidney cannot reabsorb 100% of solutes; a minimum amount of "obligatory" solute excretion is always required, preventing the osmolality from dropping this low. **3. High-Yield Clinical Pearls for NEET-PG:** * **Maximum Urine Concentration:** The human kidney can concentrate urine up to **1200–1400 mOsm/L** (under the influence of maximum ADH). * **Obligatory Urine Volume:** To excrete the daily metabolic waste (approx. 600 mOsm/day), the minimum urine volume required is about **0.5 L/day** (600 mOsm ÷ 1200 mOsm/L). * **Specific Gravity Correlation:** A urine osmolality of 50 mOsm/L corresponds to a specific gravity of approximately **1.001**, whereas 1200 mOsm/L corresponds to ~**1.030**. * **Diabetes Insipidus:** Patients with DI cannot concentrate urine and will consistently produce urine near the minimum osmolality (50–100 mOsm/L) despite dehydration.

Question 154: In Bartter syndrome, the defect lies in which part of the nephron?

A. Distal convoluted tubule
B. Thick ascending limb of loop of Henle (Correct Answer)
C. Thin ascending limb of loop of Henle
D. Proximal convoluted tubule

Explanation: **Explanation:** **Bartter syndrome** is a group of autosomal recessive genetic disorders characterized by a defect in the salt-reabsorption mechanism in the **Thick Ascending Limb (TAL) of the Loop of Henle**. The primary defect involves the **NKCC2 transporter** (Sodium-Potassium-2-Chloride cotransporter), or associated channels like ROMK (potassium exit) and CLC-Kb (chloride exit). Because the TAL is responsible for reabsorbing approximately 25% of filtered sodium, a defect here mimics the chronic use of **Loop Diuretics** (e.g., Furosemide). This leads to massive salt wasting, secondary hyperaldosteronism, hypokalemia, and metabolic alkalosis. **Analysis of Options:** * **Option A (Distal Convoluted Tubule):** This is the site of defect in **Gitelman syndrome** (specifically the NCCT transporter). Gitelman's mimics Thiazide diuretic use and is characterized by hypocalciuria, whereas Bartter often presents with hypercalciuria. * **Option C (Thin Ascending Limb):** This segment is primarily involved in passive transport and lacks the active transporters (NKCC2) targeted in Bartter syndrome. * **Option D (Proximal Convoluted Tubule):** Defects here result in **Fanconi Syndrome**, characterized by global malabsorption of glucose, amino acids, and phosphates, leading to Type 2 Renal Tubular Acidosis. **Clinical Pearls for NEET-PG:** * **Bartter vs. Gitelman:** Bartter presents early in life (polyhydramnios, infancy) with **hypercalciuria** (stones). Gitelman presents later (adolescence) with **hypocalciuria** and hypomagnesemia. * **Liddle Syndrome:** Often confused with these, but it involves a *gain of function* in ENaC channels (Collecting Duct), leading to **hypertension** rather than salt wasting. * **Mnemonic:** **B**artter = **B**ig loop (Loop of Henle); **G**itelman = **G**raduate (older age/DCT).

Question 155: If the renal plasma flow (RPF) is 600 mL/min and the hematocrit (hct) is 45%, what is the renal blood flow?

A. 1000 mL/min
B. 1090 mL/min (Correct Answer)
C. 1200 mL/min
D. 1250 mL/min

Explanation: ### Explanation **1. Understanding the Correct Answer (Option B: 1090 mL/min)** Renal Blood Flow (RBF) represents the total volume of blood delivered to the kidneys per unit time. Blood consists of two main components: **Plasma** and **Formed Elements (primarily RBCs)**. The Hematocrit (Hct) represents the fraction of blood occupied by cells. Therefore, the remaining fraction $(1 - \text{Hct})$ represents the Plasma. The mathematical relationship is: $$\text{RBF} = \frac{\text{Renal Plasma Flow (RPF)}}{1 - \text{Hematocrit}}$$ **Calculation:** * RPF = 600 mL/min * Hct = 45% (0.45) * Plasma fraction = $1 - 0.45 = 0.55$ * $\text{RBF} = \frac{600}{0.55} \approx \mathbf{1090.9 \text{ mL/min}}$ **2. Analysis of Incorrect Options** * **Option A (1000 mL/min):** This is a common distractor for students who incorrectly assume a standard RBF without calculating based on the provided Hct. * **Option C (1200 mL/min):** This value is often cited as the "average" RBF in a 70kg male, but it does not fit the specific parameters given in this mathematical problem. * **Option D (1250 mL/min):** This would be the result if the Hct were 52% or if the student confused the calculation with GFR/Filtration Fraction constants. **3. Clinical Pearls & High-Yield Facts for NEET-PG** * **Normal RBF:** Approximately 1100–1200 mL/min (roughly 20-25% of Cardiac Output). * **Normal RPF:** Approximately 600–650 mL/min. * **Filtration Fraction (FF):** $\text{GFR} / \text{RPF}$ (Normal $\approx 0.20$ or 20%). * **Gold Standard for RPF:** Para-aminohippuric acid (PAH) clearance, as it is both filtered and secreted. * **Autoregulation:** RBF remains constant between a Mean Arterial Pressure (MAP) of **80–180 mmHg** via myogenic and tubuloglomerular feedback mechanisms.

Question 156: Autosomal variant of nephrogenic diabetes insipidus is due to defect in which of the following?

A. Aquaporin 2 (Correct Answer)
B. Angiotensin I receptor
C. Angiotensin II receptor
D. VIP receptors

Explanation: **Explanation:** **Nephrogenic Diabetes Insipidus (NDI)** is characterized by the kidney's inability to concentrate urine despite adequate levels of Antidiuretic Hormone (ADH/Vasopressin). * **Why Aquaporin 2 is correct:** ADH normally binds to V2 receptors on the basolateral membrane of the collecting duct, triggering a cAMP pathway that inserts **Aquaporin-2 (AQP2)** channels into the apical membrane to facilitate water reabsorption. * The most common form of hereditary NDI is **X-linked recessive** (90%), caused by a mutation in the **V2 receptor**. * The **Autosomal (recessive or dominant) variant** of NDI is caused by mutations in the **Aquaporin-2 gene**, leading to defective water channels. **Analysis of Incorrect Options:** * **Options B & C (Angiotensin I & II receptors):** These are involved in blood pressure regulation and aldosterone secretion via the Renin-Angiotensin-Aldosterone System (RAAS). They do not directly mediate the water-permeability effects of ADH in the collecting duct. * **Option D (VIP receptors):** Vasoactive Intestinal Peptide (VIP) is involved in smooth muscle relaxation and intestinal secretion, but it plays no role in the renal concentrating mechanism associated with Diabetes Insipidus. **High-Yield Clinical Pearls for NEET-PG:** * **Lithium:** The most common cause of *acquired* nephrogenic DI (it inhibits cAMP formation). * **V1 Receptors:** Located on vascular smooth muscle (cause vasoconstriction). * **V2 Receptors:** Located in the principal cells of the collecting duct (mediate water reabsorption). * **Diagnosis:** NDI is confirmed when there is no increase in urine osmolality following the administration of exogenous ADH (Desmopressin) during a water deprivation test.

Question 157: Ion ligand receptors are:

A. Glycine receptor (Correct Answer)
B. beta adrenergic receptors
C. V1 receptor
D. Insulin receptor

Explanation: **Explanation:** The question asks to identify an **Ionotropic receptor** (Ion-ligand gated channel). These are membrane proteins that act as both a receptor and an ion channel, allowing rapid flux of ions across the cell membrane upon ligand binding. **1. Why Glycine receptor is correct:** The **Glycine receptor** is a classic example of an ionotropic receptor. It is a ligand-gated **chloride (Cl⁻) channel**. When glycine binds, the channel opens, leading to Cl⁻ influx, which causes hyperpolarization of the postsynaptic membrane, resulting in fast inhibitory neurotransmission (primarily in the spinal cord and brainstem). Other examples include Nicotinic ACh, GABA-A, and NMDA receptors. **2. Why other options are incorrect:** * **Beta-adrenergic receptors:** These belong to the **G-Protein Coupled Receptor (GPCR)** family (specifically Gs). They work via the adenylyl cyclase-cAMP second messenger system, not by direct ion gating. * **V1 receptor:** These are Vasopressin receptors (V1a and V1b) that are **GPCRs** coupled to the Gq pathway, activating Phospholipase C and increasing intracellular calcium. * **Insulin receptor:** This is an **Enzyme-linked receptor** (specifically a Receptor Tyrosine Kinase). Binding triggers autophosphorylation of tyrosine residues, initiating a phosphorylation cascade. **High-Yield Clinical Pearls for NEET-PG:** * **Strychnine:** A potent convulsant that acts as a competitive antagonist at Glycine receptors, leading to unchecked muscular contractions. * **Fastest Receptors:** Ionotropic receptors (milliseconds) > GPCRs (seconds) > Enzyme-linked (minutes/hours) > Nuclear receptors (hours/days). * **V2 Receptors:** Unlike V1, V2 receptors (found in renal collecting ducts) are GPCRs coupled to **Gs**, increasing cAMP to insert Aquaporin-2 channels.

Question 158: A freely filterable substance that is neither reabsorbed nor secreted has a renal artery concentration of 12 mg/mL and a renal vein concentration of 9 mg/mL. Which of the following is the filtration fraction?

A. 0.05
B. 0.15
C. 0.25 (Correct Answer)
D. 0.35

Explanation: ### Explanation **1. Understanding the Correct Answer (C: 0.25)** The **Filtration Fraction (FF)** is the ratio of the Glomerular Filtration Rate (GFR) to the Renal Plasma Flow (RPF): $$FF = \frac{GFR}{RPF}$$ In this scenario, we use the Fick Principle and the properties of the substance provided: * **The Substance:** Since it is freely filtered but neither reabsorbed nor secreted, the amount filtered at the glomerulus is exactly equal to the amount excreted. * **The Extraction:** The concentration drops from 12 mg/mL (Artery) to 9 mg/mL (Vein). This means 3 mg/mL was removed by the kidneys via filtration. * **The Calculation:** The fraction of plasma filtered is the amount removed divided by the total amount that entered the kidney. $$FF = \frac{\text{Arterial Concentration} - \text{Venous Concentration}}{\text{Arterial Concentration}}$$ $$FF = \frac{12 - 9}{12} = \frac{3}{12} = 0.25$$ **2. Why Other Options are Incorrect** * **A (0.05) & B (0.15):** These values represent a lower-than-normal filtration fraction, which would occur if the GFR decreased significantly (e.g., acute kidney injury) or RPF increased disproportionately. * **D (0.35):** This represents an abnormally high filtration fraction, often seen in states of efferent arteriolar constriction (e.g., effect of Angiotensin II), where GFR is maintained despite lower RPF. **3. NEET-PG Clinical Pearls & High-Yield Facts** * **Normal FF:** In a healthy adult, the normal filtration fraction is approximately **0.20 (20%)**. * **Inulin vs. PAH:** Inulin is the gold standard for GFR (filtered, not reabsorbed/secreted). Para-aminohippurate (PAH) is used to measure Effective Renal Plasma Flow (ERPF) because it is both filtered and secreted. * **Effect of SNS/Angiotensin II:** Sympathetic stimulation and Angiotensin II constrict the efferent arteriole more than the afferent, leading to an **increase in FF** to maintain GFR during low-pressure states. * **Formula Shortcut:** If a substance is only filtered (like Inulin), its extraction ratio ($E = \frac{A-V}{A}$) is numerically equal to the Filtration Fraction.

Question 159: Which mechanism does NOT contribute to the countercurrent multiplier in the nephron?

A. Active transport of sodium and chloride out of the thick ascending limb of the loop of Henle
B. Water reabsorption in the thin descending limb of the loop of Henle
C. Sodium reabsorption out of the thin descending limb of the loop of Henle (Correct Answer)
D. Urea concentration in the collecting duct

Explanation: The **Countercurrent Multiplier** is the process by which the loop of Henle creates an osmotic gradient in the renal medulla, essential for urine concentration. ### Why Option C is Correct The **thin descending limb (tDLH)** is highly permeable to water but has **low to zero permeability** for solutes like sodium and urea. In this segment, water moves out into the hypertonic interstitium via osmosis, but sodium does not move out. In fact, a small amount of sodium may actually enter the tDLH. Therefore, sodium reabsorption in this segment does not contribute to the multiplier effect. ### Why Other Options are Incorrect * **Option A:** This is the "Single Effect" and the primary driver of the multiplier. The **thick ascending limb (TAL)** actively pumps Na⁺, K⁺, and Cl⁻ (via the NKCC2 transporter) into the interstitium, making it hypertonic. * **Option B:** Water reabsorption in the tDLH concentrates the tubular fluid, ensuring that the fluid reaching the ascending limb has a high salt concentration, which facilitates further salt transport. * **Option D:** Urea recycling is a critical component. High concentrations of urea in the medullary collecting duct diffuse into the deep medullary interstitium, contributing nearly 50% of the total osmolarity during dehydration. ### High-Yield NEET-PG Pearls * **Countercurrent Multiplier:** Loop of Henle (creates the gradient). * **Countercurrent Exchanger:** Vasa Recta (maintains the gradient by removing excess water). * **NKCC2 Transporter:** Target of **Loop Diuretics** (e.g., Furosemide), which abolish the medullary gradient. * **ADH (Vasopressin):** Increases urea permeability in the medullary collecting ducts via UT-A1 transporters, further strengthening the gradient.

Question 160: Which receptors are responsible for the relaxation of the detrusor muscle?

A. Beta-1 adrenergic receptors
B. Beta-2 adrenergic receptors (Correct Answer)
C. Alpha-1 adrenergic receptors
D. Alpha-2 adrenergic receptors

Explanation: ### Explanation The filling and storage phase of the bladder is governed by the **Sympathetic Nervous System** (T11–L2), which promotes urinary retention by relaxing the bladder wall and contracting the outlet. **1. Why Beta-2 Adrenergic Receptors are Correct:** The detrusor muscle contains predominantly **Beta-2 (and Beta-3)** adrenergic receptors. Stimulation of these receptors by norepinephrine leads to the activation of adenylyl cyclase, increasing intracellular cAMP. This results in smooth muscle relaxation, allowing the bladder to expand and accommodate increasing volumes of urine at low pressure (cystometric "filling phase"). *Note: While Beta-3 is the most abundant subtype in the human detrusor, Beta-2 is the classic physiological answer frequently tested in exams.* **2. Analysis of Incorrect Options:** * **Beta-1 Adrenergic Receptors:** These are primarily located in the **heart** (increasing heart rate and contractility) and the juxtaglomerular apparatus (renin release). They have no significant role in bladder wall dynamics. * **Alpha-1 Adrenergic Receptors:** These are located in the **internal urethral sphincter** and the bladder neck. Stimulation causes **contraction**, which increases outlet resistance to prevent urination. * **Alpha-2 Adrenergic Receptors:** These are primarily presynaptic receptors that inhibit further neurotransmitter release; they do not directly mediate detrusor relaxation. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Mnemonic (Sympathetic):** **S**ympathetic = **S**torage. It relaxes the wall (Beta-2/3) and closes the door (Alpha-1). * **Parasympathetic (S2–S4):** Mediated by **M3 receptors**, causing detrusor **contraction** (emptying). * **Pharmacology Link:** **Mirabegron** is a selective **Beta-3 agonist** used to treat overactive bladder by promoting detrusor relaxation. * **Somatice Control:** The **Pudendal nerve** (S2–S4) controls the external urethral sphincter via Nicotinic (Nm) receptors, providing voluntary control over micturition.

Practice by Chapter

Renal Blood Flow and Glomerular Filtration

Practice Questions

Tubular Reabsorption and Secretion

Practice Questions

Concentration and Dilution of Urine

Practice Questions

Acid-Base Regulation by the Kidneys

Practice Questions

Sodium and Water Balance

Practice Questions

Potassium Regulation

Practice Questions

Calcium and Phosphate Handling

Practice Questions

Micturition Physiology

Practice Questions

Renal Function Tests

Practice Questions

Integrative Responses to Fluid Challenges

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free